Skip to content

Clinical trials

Muscular Atrophy trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Atrophy Country / region: China Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20191
20222
20242
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting2
Not yet recruiting2
Unknown status2
Completed1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Nanjing Medical University1
National Clinical Research Center for Orthopedics, Sports Medicine and Rehabilitation, China1
Shanghai Zhongshan Hospital1
Sichuan Provincial People's Hospital1
Universiteit Antwerpen1
Yunfeng Xia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Atrophy8
Frailty2
Muscular Atrophy, Spinal2
Muscular Diseases2
Sarcopenia2
Bulbo-Spinal Atrophy, X-Linked1
Burns1
Inflammation1
Insulin Resistance1
Liver Cirrhosis1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.